Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipovir Gel versus Zovirax Cream and placebo for recurrent herpes labialis
2023-510338-10-00Phase 3Authorised
- Sponsor
- Ojer Pharma
- Start
- Jan 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in herpes labialis comparing Lipovir Gel, Zovirax Cream and Placebo (3 arms). Primary endpoint: Duration of Episode. Planned start Jan 2025; status: authorised.
02
Drugs
acycloviraciclovir
03
Conditions
herpes labialis
Beyond the preview
Go deeper on 2023-510338-10-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-510338-10-00.